The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.
Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.
The FDA has expanded the approval of Sarepta Therapeutics' gene therapy, Elevidys, for Duchenne muscular dystrophy in patients aged four and older, addressing both ambulatory and non-ambulatory cases.
Reuters
Daily News
Stay up to date with the latest clinical headlines.
The U.S. Preventive Services Task Force recommends intensive behavioral interventions for children and adolescents with high BMI to manage weight and improve health.
The FDA classifies the recall of Teleflex's inflatable heart devices as "most serious" due to risks of serious injury or death from a manufacturing error.
Biomea Fusion announced a clinical hold by the U.S. FDA on its diabetes drug trial due to potential toxic liver disease, causing a 60% drop in its shares.